Anthony Martinez, MD, AAHIVS
Associate Professor of Medicine
University at Buffalo, School of Medicine
- Discuss the rates of HCV re-infection after HCV treatment.
- Discuss key populations at risk for re-infection.
- Discuss methods to decrease re-infection rates and address treatment in patients with re-infection.
The target audience is health care professionals interested in HIV/HCV/STD/Drug User Health continuing medical education.
The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Rochester School of Medicine and Dentistry designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Rochester Center for Nursing Professional Development is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.0 Nursing Contact Hours will be provided.
ACCME Standards for Commercial Support of CME require that presentations be free of commercial bias and that any information regarding commercial products/services be based on scientific methods generally accepted by the medical community. When discussing therapeutic options, speakers are requested to use only generic names. If they use a trade name, then those of several companies should be used. If a presentation includes discussion of any unlabeled or investigational use of a commercial product, speakers are required to disclose this to the participants.
No commercial funds have been received to support this educational activity.
Planning Committee and Speakers Disclosures:
A conflict of interest (COI) occurs when an individual has an opportunity to affect educational content about healthcare products or services of a commercial interest with which she/he has a financial relationship and/or personal relationship. The following planners and presenters of this CNE/CME activity have disclosed no relevant personal or financial relationships with any commercial interests pertaining to this activity: Cherry Jones, MA, MSW; Emily Scognamiglio, MPH; Angelica Ramirez, MPA; Jeffrey Weiss, PhD; Linda Wang, MD; Monica Barbosu, MD, PhD; Oksana Babiy, BS, Tamara Eis, MS, RN-BC.
Anthony Martinez, MD, AAHIVS has disclosed the following relevant financial disclosures in the past 12 months with manufacturers of the product or services that may be presented in this activity: Consultant:Gilead, Abbvie; Grant/Research Support: Gilead, Intercept, Allergan; Speakers’ Bureau: AbbVie, Gilead, Eaisai.
- This online video and post-activity evaluation are 60 min. in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must pass the quiz with a score of 80% or higher to receive the CE certificate.
- If successful, you will be provided instructions to print your CE certificate at the completion of this activity.
Bibliographic Sources to Allow for Further Study:
- Falade-Nwulia, O., Sulkowski, M. S., Merkow, A., Latkin, C., & Mehta, S. H. (2018). Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era.Journal of viral hepatitis,25(3), 220–227. https://doi.org/10.1111/jvh.12859
- Midgard, H., Weir, A., Palmateer, N., Re III, V. L., Pineda, J. A., Macías, J., & Dalgard, O. (2016). HCV epidemiology in high-risk groups and the risk of reinfection.Journal of hepatology,65(1), S33-S45.